Immunique Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2.72M

  • Investors
  • 2

Immunique General Information

Description

Developer of cell-based therapeutics designed to provide treatments for incurable diseases such as autoimmune diseases and cancer. The company specializes in composing therapeutics and drugs using pure cells rather than peripheral blood or bone marrow cells, enabling healthcare professionals to maximize the function of cord blood and treat various diseases.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6th Floor, 21, Daewangpangyo-ro 644beon-gil
  • 672-4, Sampyeong-dong, Bundang-gu
  • Seongnam, Gyeonggi
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Drug Delivery
Parent Company
Corporate Office
  • 6th Floor, 21, Daewangpangyo-ro 644beon-gil
  • 672-4, Sampyeong-dong, Bundang-gu
  • Seongnam, Gyeonggi
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunique Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 05-Oct-2021 $2.72M Completed Pre-Clinical Trials
1. Merger/Acquisition 01-Apr-2021 Completed Pre-Clinical Trials
To view Immunique’s complete valuation and funding history, request access »

Immunique Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Immunique FAQs

  • When was Immunique founded?

    Immunique was founded in 2021.

  • Where is Immunique headquartered?

    Immunique is headquartered in Seongnam, South Korea.

  • What is the size of Immunique?

    Immunique has 12 total employees.

  • What industry is Immunique in?

    Immunique’s primary industry is Drug Discovery.

  • Is Immunique a private or public company?

    Immunique is a Private company.

  • What is the current valuation of Immunique?

    The current valuation of Immunique is .

  • What is Immunique’s current revenue?

    The current revenue for Immunique is .

  • How much funding has Immunique raised over time?

    Immunique has raised $2.72M.

  • When was Immunique acquired?

    Immunique was acquired on 05-Oct-2021.

  • Who acquired Immunique?

    Immunique was acquired by Medipost.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process